-

10:56:46 AM

Latest MRNA Stock Market News

MRNA - Moderna Inc

06/18/21 7:01 AM

Nasdaq : MRNA

Moderna Reaffirms Commitment to Job Creation in Massachusetts

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today reaffirmed its commitment to job creation in Massachusetts. Over the last year, Moderna nearly doubled the size of its workforce, from approximately 830 employees as of March 31,

RHEA-AI

neutral

06/16/21 8:00 AM

Nasdaq : MRNA

U.S. Government Purchases Additional 200 Million Doses of Moderna’s COVID-19 Vaccine

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the U.S. government has purchased an additional 200 million doses of Moderna’s COVID-19 vaccine, including the option to purchase other COVID-19 vaccine candidates

RHEA-AI

neutral

06/15/21 9:43 AM

Nasdaq : MRNA

Moderna and Magenta Partner to Distribute Moderna’s COVID-19 Vaccine and Updated Variant Booster Candidates in United Arab Emirates

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Magenta Investments, a leading pharmaceutical and healthcare company that is part of an investment and industrial conglomerate in the United Arab Emirates (UAE), today announced a

RHEA-AI

neutral

06/14/21 4:45 PM

Nasdaq, NYSE : MRNA, RFL

Rafael Holdings Appoints Three Highly Experienced Biopharmaceutical Leaders to its Board of Directors

Rafael Holdings, Inc., (NYSE: RFL), a pharmaceutical company focused on developing novel cancer metabolism therapeutics, today announced the appointment of three senior biopharmaceutical leaders to its Board of Directors: Ameet Mallik, Chief Executive

RHEA-AI

very positive

06/14/21 8:10 AM

Nasdaq : MRNA

Dr. Paul Burton to Join Moderna as Chief Medical Officer

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Paul Burton, M.D., Ph.D., F.A.C.C, M.R.C.S will join the Company as Chief Medical Officer, effective July 6, 2021. He will serve on Moderna’s Executive Committee and

RHEA-AI

neutral

06/14/21 7:07 AM

Nasdaq : MRNA

Moderna Submits Authorization Application for its COVID-19 Vaccine in Adolescents in Switzerland

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has submitted an authorization application to Swissmedic for use of its COVID-19 vaccine in adolescents.“We are pleased to announce that we have submitted an

RHEA-AI

neutral

06/11/21 8:30 AM

Nasdaq : MRNA

Moderna and Tabuk Pharmaceuticals Partner to Commercialize Moderna’s COVID-19 Vaccine in Saudi Arabia

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary of Astra Industrial Group), a leading Saudi pharmaceuticals company, today announced an agreement to

RHEA-AI

very positive

06/10/21 8:00 AM

Nasdaq : MRNA

Moderna Files for Emergency Use Authorization for its COVID-19 Vaccine in Adolescents in the United States

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has requested an emergency use authorization (EUA) for its COVID-19 vaccine in adolescents with the U.S. Food and Drug Administration (FDA).“We are pleased to

RHEA-AI

neutral

06/07/21 8:00 AM

Nasdaq : MRNA

Moderna and Medison Pharma Partner to Commercialize Moderna’s COVID-19 Vaccine Across Central Eastern Europe and Israel

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Medison Pharma, a leading commercial partner for highly innovative therapies in international markets, today announced a new agreement to commercialize the Moderna COVID-19 Vaccine

RHEA-AI

very positive

06/07/21 7:49 AM

Nasdaq : MRNA

Moderna Files for Authorization with Health Canada for its COVID-19 Vaccine in Adolescents

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has submitted for authorization of its COVID-19 vaccine in adolescents with Health Canada.“We are pleased to announce that we have submitted for authorization

RHEA-AI

neutral

1 2 3 4 5 6 7 8 9 10 Next